81 related articles for article (PubMed ID: 2526212)
1. Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion.
Stevens CW; Yaksh TL
J Pharmacol Exp Ther; 1989 Jul; 250(1):1-8. PubMed ID: 2526212
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of dose-dependent antagonism by beta-funaltrexamine of the antinociceptive effects of intrathecal mu agonists.
Mjanger E; Yaksh TL
J Pharmacol Exp Ther; 1991 Aug; 258(2):544-50. PubMed ID: 1650833
[TBL] [Abstract][Full Text] [Related]
3. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
[TBL] [Abstract][Full Text] [Related]
4. Spinal infusion of opiate and alpha-2 agonists in rats: tolerance and cross-tolerance studies.
Stevens CW; Monasky MS; Yaksh TL
J Pharmacol Exp Ther; 1988 Jan; 244(1):63-70. PubMed ID: 2891846
[TBL] [Abstract][Full Text] [Related]
5. Time course characteristics of tolerance development to continuously infused antinociceptive agents in rat spinal cord.
Stevens CW; Yaksh TL
J Pharmacol Exp Ther; 1989 Oct; 251(1):216-23. PubMed ID: 2795458
[TBL] [Abstract][Full Text] [Related]
6. Magnitude of opioid dependence after continuous intrathecal infusion of mu- and delta-selective opioids in the rat.
Stevens CW; Yaksh TL
Eur J Pharmacol; 1989 Aug; 166(3):467-72. PubMed ID: 2553435
[TBL] [Abstract][Full Text] [Related]
7. Studies of morphine and D-ala2-D-leu5-enkephalin (DADLE) cross-tolerance after continuous intrathecal infusion in the rat.
Stevens CW; Yaksh TL
Anesthesiology; 1992 Apr; 76(4):596-603. PubMed ID: 1550284
[TBL] [Abstract][Full Text] [Related]
8. Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats.
Paronis CA; Holtzman SG
J Pharmacol Exp Ther; 1992 Jul; 262(1):1-9. PubMed ID: 1625189
[TBL] [Abstract][Full Text] [Related]
9. Chronic spinal infusion of dexmedetomidine, ST-91 and clonidine: spinal alpha 2 adrenoceptor subtypes and intrinsic activity.
Takano Y; Yaksh TL
J Pharmacol Exp Ther; 1993 Jan; 264(1):327-35. PubMed ID: 8093729
[TBL] [Abstract][Full Text] [Related]
10. Cross-tolerance between mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus.
Garaulet JV; Laorden ML; Milanés MV
J Pharmacol Exp Ther; 1994 Jun; 269(3):993-9. PubMed ID: 8014886
[TBL] [Abstract][Full Text] [Related]
11. Differential cross-tolerance between intrathecal morphine and sufentanil in the rat.
Sosnowski M; Yaksh TL
Anesthesiology; 1990 Dec; 73(6):1141-7. PubMed ID: 1978988
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal morphine and clonidine: antinociceptive tolerance and cross-tolerance and effects on blood pressure.
Solomon RE; Gebhart GF
J Pharmacol Exp Ther; 1988 May; 245(2):444-54. PubMed ID: 3367301
[TBL] [Abstract][Full Text] [Related]
13. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1989 May; 249(2):462-9. PubMed ID: 2566676
[TBL] [Abstract][Full Text] [Related]
14. Tolerance and cross-tolerance to the antisecretory effects of enkephalins on the guinea-pig ileal mucosa.
Vinayek R; Brown DR; Miller RJ
J Pharmacol Exp Ther; 1985 Mar; 232(3):781-5. PubMed ID: 2983070
[TBL] [Abstract][Full Text] [Related]
15. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
16. Spinal infusion of N-methyl-D-aspartate antagonist MK801 induces hypersensitivity to the spinal alpha-2 agonist ST91 in the rat.
Dunbar SA; Yaksh TL
J Pharmacol Exp Ther; 1997 Jun; 281(3):1219-25. PubMed ID: 9190856
[TBL] [Abstract][Full Text] [Related]
17. Perspectives on opioid tolerance from basic research: behavioural studies after spinal administration in rodents.
Stevens CW
Cancer Surv; 1994; 21():25-47. PubMed ID: 8564997
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
[TBL] [Abstract][Full Text] [Related]
19. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
Locke KW; Holtzman SG
J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
[TBL] [Abstract][Full Text] [Related]
20. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
Locke KW; Holtzman SG
J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
